Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

841 - 850 of 44782 results found

Human transferrin receptor can mediate SARS-CoV-2 infection

Date
Monday, February 26, 2024 - 4:00 AM
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been detected in almost all organs of coronavirus disease-19 patients, although some organs do not express angiotensin-converting enzyme-2 (ACE2), a known receptor of SARS-CoV

Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition

Date
Monday, February 26, 2024 - 4:00 AM
Description
Coronavirus transmission and mutations have brought intensive challenges on pandemic control and disease treatment. Developing robust and versatile antiviral drugs for viral neutralization is highly desired. Here, we created a new polyvalent nanobody

RNA Therapeutics for the Cardiovascular System

Date
Monday, February 26, 2024 - 4:00 AM
Description
RNA therapeutics hold significant promise in the treatment of cardiovascular diseases. RNAs are biologically diverse and functionally specific and can be used for gain- or loss-of-function purposes. The effectiveness of mRNA-based vaccines in the

Linguistic analysis of health anxiety during the COVID-19 pandemic

Date
Monday, February 26, 2024 - 4:00 AM
Description
Health anxiety, which is defined as fear of having or contracting serious physical illness, is particularly salient in light of the COVID-19 pandemic. We conducted a mixed methods study in which 578 narrative samples were analyzed using Linguistic